Earlier CRC screening with colonoscopy, FIT cost-effective ‘irrespective of BMI’

Regardless of patient sex or BMI, initiating colorectal cancer screening with colonoscopy at age 45 years or with fecal immunochemical testing at age 40 years was cost-effective, according to new research.In addition, researchers reported CRC screening with colonoscopy at age 40 years was cost-effective in men with class 2 and 3 obesity, whom investigators noted have the highest risk for CRC and all-cause mortality.“Initiating CRC colonoscopy-based screening at age 45 years is likely to be cost-effective for women and men irrespective of BMI, initiating colonoscopy-based screening atRead More